Donald J. Trump
http://www.trumponline.com/Donald Trump is a real estate developer, American business executive, and entrepreneur. He is the CEO of Trump Organization, a real estate development company based in New York.
Trump graduated from the Wharton School of Business at the University of Pennsylvania in 1968 with a BS in economics and a concentration in finance. He then joined his father's company, the Trump Organization, where he developed and revitalized properties in Manhattan.
Trump found additional success as a TV star on the hit show The Apprentice, where he coined the term 'You're Fired!'.
In 2016, Trump ran for President of the U.S. as a Republican. After topping a large field of 16 other Republicans he was selected as the nominees. He then faced Democrat Hillary Clinton and beat her in a contentious race to become President of the U.S. Trump's platform of 'Make America Great Again' and 'Drain the Swamp' resonated with white, working class citizens.
-
Investors eye discounted U.S. healthcare sector as Biden's lead in polls grows
-
Trump says not pressing U.S. government for coronavirus vaccine for political reasons
-
U.S., European COVID-19 vaccine developers pledge to uphold testing rigour
-
AstraZeneca contacted Gilead over potential megamerger: Bloomberg News
-
S&P 500 rises on economic recovery and vaccine hopes, pulls back from highs
-
Wall Street Week Ahead: Investors prepare for more U.S. stock swings as states reopen
-
Trade optimism, Fed rate-cut expectation sends S&P 500 to record
-
S&P 500 nears record high on trade progress, upbeat Intel earnings
-
Wall Street drops after China cancels trip to Montana farmland
-
Tech pulls Wall Street lower on Trump trade warning
-
Trump's attorney general nominee vows to shield Russia probe from politics
-
Health stocks up on U.S. vote; insurers hit records
-
From pharma to prisons, election-sensitive stocks that could swing
-
Merck, Bristol-Myers profits rise on cancer drug sales
-
U.S. to propose TV ads for drugs must include list prices
-
Merck's Frazier to remain CEO of the U.S. drugmaker beyond 2019
-
U.S. health secretary says agency can eliminate drug rebates
-
Pharma's middlemen see shares suffer as challenges grow
-
Amid drug price worries, earnings to test U.S. pharma, biotech shares
-
Wall Street rises but pares gains late after report of FBI raid
-
Trump taps ex-pharma executive Azar as U.S. health secretary
-
Wall St. powered higher by tech, Amazon results
-
Jamie Dimon ventures beyond Wall Street to have a say in Washington
-
President Trump Announces End of Strategic & Policy Forum and Manufacturing Council on Twitter
-
Trump Tweets Now that Ken Frazier of Merck Pharma (MRK) has resigned from President's Manufacturing Council, he will have more time to LOWER RIPOFF DRUG PRICES!
-
Trump yields to pressure, calls neo-Nazis and KKK criminals
-
Merck (MRK) and Pfizer (PFE) Collaborate with Corning (GLW) to Modernize Pharmaceutical Glass Packaging
-
Merck and Pfizer Collaborate with Corning to Modernize Pharmaceutical Glass Packaging
-
'It's like kumbaya': Trump's genial private meetings with CEOs jar with public attacks
-
Pharma Stocks Drop After Trump Tweets Drug Prices Will 'Come Way Down!' (IBB)
-
Trump again vows to bring back U.S. jobs, but offers few details
-
CEOs of 16 U.S. companies urge Congress to pass border tax
-
Merck reveals seven years of its U.S. drug price increase history
-
Wall Street ends higher as Trump becomes president
-
Trump Calls for New Bidding Procedures on Drugs; Related Stocks Decline (IBB)
-
Wall Street opens flat ahead of Trump conference
-
S&P ends flat as healthcare advance offset by lower oil
-
Wall Street extends rally in sharp New Year's rise
-
Trump's corporate tax holiday could spur pharma M&A
-
Wall Street slips, led by healthcare decline
-
Complete Donald Trump Stock Impact Guide